Generics

Innovative Products found!

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-060 manufacturers

Filters

None products found

pp-060

Tablets

Dossier type
CTD
Dossier status
Under development
Country of origin
South Korea
Comments
Indication: Autism spectrum disorder (ASD), including pediatric patients with social-communication deficits and neurobehavioral symptoms; additional evaluation in neurological conditions characterized by lysosomal dysfunction, mitochondrial stress, and dopaminergic pathway abnormalities. Clinical stage: Phase 2 clinical development in pediatric ASD, supported by completed Phase 1 PK/PD modeling and randomized placebo-controlled studies. Modality: Small molecule (essential amino acid formulation) Mechanism / Target: Pharmaceutical-grade L-serine supporting neuronal metabolism; modulates mitochondrial function, reduces oxidative and lysosomal stress, restores cathepsin activity, and improves dopaminergic neuronal signaling—mechanisms implicated in ASD pathophysiology. Route / form: Oral administration (dose-titrated formulations used in clinical studies) Differentiation: First-in-class neurometabolic therapy targeting cellular stress pathways in ASD; demonstrated improvements in social communication in clinical trials and robust neuroprotective effects in multiple preclinical models.
Manufacturer #38614

 clinical-stage biopharmaceutical company developing small molecule-based therapies for intractable neurological disorders, including autism spectrum disorder. It focuses on rapid translation from clinical insight to treatment options with global development and partnership goals. The organization leverages clinician-led research to advance patient-relevant medicines.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.